ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,780, issued on April 15, was assigned to AMLO Biosciences Ltd. (Newcastle Upon Tyne, Great Britain).
"Monoclonal antibodies against Ambra-1" was invented by Penny Lovat (Newcastle Upon Tyne, Great Britain), Marie Labus (Newcastle Upon Tyne, Great Britain), Rob Ellis (Newcastle Upon Tyne, Great Britain) and Ashleigh McConnell (Newcastle Upon Tyne, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates inter alia to the development of monoclonal antibodies against Ambra-1 and methods for determining whether a subject with melanoma has an increased risk of metastasis using said antibodies."
The patent was filed on No...